Computational Crystallization by Altan, Irem et al.
Computational Crystallization
Irem Altan,1 Patrick Charbonneau,1, 2 and Edward H. Snell3, 4
1Department of Chemistry, Duke University, Durham, NC 27708, USA
2Department of Physics, Duke University, Durham, NC 27708, USA
3Hauptman-Woodward Medical Research Institute, 700 Ellicott St. NY 14203, USA
4Department of Structural Biology, SUNY University of Buffalo, 700 Ellicott St. NY 14203, USA
Crystallization is a key step in macromolecular structure determination by crystallography. While
a robust theoretical treatment of the process is available, due to the complexity of the system,
the experimental process is still largely one of trial and error. In this article, efforts in the field
are discussed together with a theoretical underpinning using a solubility phase diagram. Prior
knowledge has been used to develop tools that computationally predict the crystallization outcome
and define mutational approaches that enhance the likelihood of crystallization. For the most part
these tools are based on binary outcomes (crystal or no crystal), and the full information contained
in an assembly of crystallization screening experiments is lost. The potential of this additional
information is illustrated by examples where new biological knowledge can be obtained and where a
target can be sub-categorized to predict which class of reagents provides the crystallization driving
force. Computational analysis of crystallization requires complete and correctly formatted data.
While massive crystallization screening efforts are under way, the data available from many of these
studies are sparse. The potential for this data and the steps needed to realize this potential are
discussed.
I. INTRODUCTION
Macromolecular crystallography is a gateway to the
detailed structure of biological molecules, and, to the bi-
ological processes in which they are involved. Its power as
a scientific tool is recognized in the remarkable number of
Nobel prizes that make direct reference to the technique.
The main drawback of the approach is that as its name
indicates it requires a crystal of the macromolecule of
interest. There lies the crux of the problem.
The National Institutes of Health Protein Structure
Initiative (PSI) targeting fold space (where all outcomes,
crystallization and non-crystallization, were tracked)
showed that out of ∼45K soluble, purified targets, ∼8K
crystallized, of which only ∼5K resulted in a crystal
structure. Later data from the PSI-Biology initiative,
which focused on targets of compelling biological interest,
showed that out of a further ∼10K targets, only ∼2K re-
sulted in a crystal structure [1]. Results from these large
datasets mirror those obtained at the large-scale crystal-
lization screening center led by one of us: the Hauptman-
Woodward Medical Research Institute High-Throughput
Screening (HTS) Laboratory [2]. An analysis of 96 bio-
logical macromolecular targets screened against a set of
1536 chemical cocktails gave 277 crystal leads (36 targets
produced one or more crystals) from ∼150K experiments,
and hence only ∼0.2% of the experiments used for screen-
ing produced crystals [3, 4]. These results thus provide
a consistent illustration of the remarkably poor success
rate of crystallization screening despite the power of the
crystallographic technique.
A meta-analysis of large-scale crystallization screening
centers reveals that out of ten soluble protein constructs,
four are likely to crystallize, of which only one on av-
erage will produce a crystal structure [5]. Because the
number of structures deposited in the Protein Data bank
(PDB) that have been determined by X-ray crystallo-
graphic methods is now over 100K, we infer that tens of
millions of experiments have had outcomes other than
diffracting crystals. Unfortunately, information on those
experiments is not reported in the PDB, and in most
cases nor are the conditions that produced a crystal but
were not used in the final structure determination. We
are thus left with datasets that incompletely capture the
effort involved in the crystallization of macromolecules.
If that were not bad enough, the data that is available of-
ten presents multiple difficulties for automated attempts
at data mining and prediction. In this article, we first
describe the crystallization process, and then show that
by utilizing the PDB-deposited structures and sequences
along with the information whether or not that sequence
produced a crystal, it is possible to provide predictive
glimpses of the experimental outcome. We then review
attempts at employing detailed screening information in
order to provide further insight. We conclude with a dis-
cussion of the incentives for improved bookkeeping and
with an outlook towards future research in computational
crystallization.
II. CRYSTALLIZATION
Crystallization has been described as an “empirical art
of rational trial and error guided by past results”[6]. For
better and for worse, this still sums up the state of the
art. When presented with a biological macromolecular
sequence it is currently impossible to know what condi-
tions will result in crystallization or even if crystallization
will occur at all. Basic predictive techniques can deter-
mine, for instance, if the target may be associated with a
membrane, providing an initial lead into the appropriate
crystallization approaches, but little further guidance is
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2available. The history of crystallization methods and the
development of modern crystallization screens have been
summarized elsewhere [7]. It is, however, important to
note that the development of readily prepared commer-
cial screens make initial crystallization screening experi-
ments easier, but at the risk of standardizing the starting
points and introducing a bias on outcome. We will not
discuss the details of the available screens or approaches
here, but rather sketch the features of these methods that
are essential to describing the role and purpose of exper-
imental crystallization data.
The main strategy in macromolecular crystallization
is to gradually bring a target solubilized in an appro-
priate aqueous chemical cocktail (containing at least a
precipitating agent and a buffer) to a region of super-
saturation until a crystal nucleates and grows. Interest-
ingly, experimental outcomes reveal that there are many
landmarks on the screening landscape that are not crys-
tals. Crystals form under solution conditions that fall
between those producing clear drops (conditions under
which macromolecular-solvent interactions are stronger
than interactions between macromolecules) and those
producing precipitate (conditions under which the oppo-
site is true). Clear and precipitate are common outcomes
but phase separation, skin-formation, and a combination
of any of these outcomes can also occur. These outcomes
are markers on the solubility landscape that can be used
to direct experiments towards a crystal [8]. For the vast
majority of reports, however, these outcomes are not cap-
tured, restricting significantly the insights that can be
gained from failed crystallization experiments into pro-
filing the phase response of a macromolecule to different
chemistries.
To understand the potential insights it is useful to re-
view the thermodynamical framework of crystallization
screening experiments. First and foremost, macromolec-
ular crystallization is a phase transition. To study the
coexistence of the crystal and the solution forms of a
macromolecule, one needs to determine the set of condi-
tions at which the chemical potentials of the two phases
are equal. The chemical potential determination from
first-principles entails knowledge of effective interactions
between macromolecules [9–12]. Unfortunately, although
the individual forces involved in macromolecular interac-
tions are well understood, there does not exist a simple
and fast way to figure out how these forces collectively
build up effective macromolecular interactions [13, 14].
Both experimental and theoretical studies of crystal-
lization inevitably involve the interpretation of phase di-
agrams. These recapitulate the conditions under which
different phases are thermodynamically stable. For mix-
tures such as crystallization cocktails, i.e. the mix-
ture of chemicals designed to drive crystallization, the
phase diagram is multi-dimensional. While not true in
general, these multi-dimensional macromolecular phase
diagrams can often be projected on the temperature-
macromolecular concentration plane. This projection
changes the temperature scale, however, as the contents
of the cocktail such as co-solutes alter the energy scale
of macromolecular interactions (while the experimental
temperature itself is barely changed). The composition
of the final phases can also be complex. A macromolec-
ular crystal, for instance, contains on average more than
50% of the mother liquor [15] and may embed co-solutes
in fractions that differ from what is left in the crystal-
lization cocktail.
The arduous task of experimentally determining phase
diagrams was carried out for a handful of proteins, in-
cluding lysozyme, γ-crystallins, insulin, and myoglobin
[16–22]. Despite the complexities introduced by the
macromolecular structure and the additives in the crys-
tallization cocktail, the phase diagrams of these proteins
resemble that of simple liquids [23], in the sense that
phases analogous to the crystal, liquid, vapor, and su-
percritical fluid are distinguishable. The phase diagram
of simple liquids (shown in Figure 1a), however, exhibits
a vapor-liquid coexistence line that terminates at a stable
critical point. Below this line (in the dark gray area) the
system is unstable, and above the critical temperature,
it is a supercritical fluid. One key difference is that for
proteins the critical point typically lies below the crys-
tal solubility line, meaning that the protein vapor and
liquid phases are metastable. For proteins (Figure 1b),
below the critical point, the system has a propensity to
aggregate in a disordered, percolating network, i.e., a gel;
the gelation probability increasing with distance to the
critical point [24, 25]. Although such an aggregation is
metastable, it can be long-lived, which arrests the crys-
tallization process in the timescale of experiments. The
area between the solubility line and the critical point is
where crystallization is most likely to occur, and has con-
sequently been dubbed the nucleation zone or crystalliza-
tion gap [26, 27].
F
T
ρ
nucleation 
zone
critical
point
(b)
S
F
T
ρ
V L
critical
point
(a)
S
FIG. 1. Phase diagram of (a) a simple liquid and (b) a simple
protein in the density-temperature plane. Vapor, liquid, solid,
and fluid phases are denoted by V, L, S, and F, respectively.
For macromolecules, the critical point lies below the solubility
line; for simple liquids, this critical point is located at the top
of the (hidden) solubility curve. A supersaturated protein
solution is typically found to be most likely to crystallize in
the nucleation zone – the region between the solubility line
and the critical point.
Macromolecular phase diagrams are informative of the
conditions in which crystallization is most likely to oc-
cur. However, their experimental determination is a task
3more challenging and time-consuming than even the most
ambitious crystallization screen. Furthermore, theoreti-
cally determining phase diagrams to guide crystalliza-
tion experiments suffers from the fundamental caveat
that the macromolecular structure is required, because
effective macromolecular interactions cannot be reliably
determined otherwise [28, 29]. Therefore, screening re-
mains the most efficient way of probing the space of so-
lution conditions [30], even though it can be done only
very sparsely. Gaining useful insights about macromolec-
ular crystal assembly requires extracting the key features
of the phase diagrams from the limited information pro-
vided by experimental screening, and hope to use insights
from simpler models to bridge the vast remaining gaps.
Hence, although we have a reasonably good understand-
ing of crystallization, the chemical space that needs to
be sampled to make use of it is remarkably vast.
III. EXPERIMENTAL CRYSTALLIZATION
DATA
The protein data bank (PDB) is the international
archive for all macromolecular structural models and, for
crystallography, the X-ray diffraction data used to build
these models. For every model in the PDB, a record ex-
ists of the crystallization conditions within an unstruc-
tured and non-mandatory remark field. Attempts have
been made to enhance the usefulness of this record by
standardizing chemical definitions and by enabling data
queries [31]. The remarks themselves have also been an-
alyzed revealing that almost 40% of the reported crystal-
lization conditions can be formed by the optimization of
a commercial screen [32]. Yet, although the PDB remains
the largest source of successful crystallization data, over
30% of its structures contain no crystallization details.
When those details are present, they are not systemati-
cally recorded, and of course, only the condition used to
produce the structural model is captured. Despite these
caveats, the information present is clearly useful. For
example, Kirkwood et al. [33] used cleaned PDB data
to confirm that acidic proteins (pI < 7) tend to crystal-
lize at 1.0 pH unit above their pI and that basic pro-
teins (pI > 7) tend to crystallize 1.5-3.0 pH units above
their pI, in agreement with previous studies [34]. How-
ever, the PDB captures no information on other chemical
conditions that may have yielded crystals, the range of
chemical space sampled, or the other experimental out-
comes that result. This is not surprising as the role of the
PDB is to capture the structural model and not the com-
plete experimental results to reproduce the result. Simi-
larly, negative results are rarely reported in the literature.
Much information that could be useful to understand the
crystallization process itself is, however, lost.
Only a couple of dedicated crystallization condi-
tion databases exist. The Biomolecular Crystallization
Database (BMCD) includes the subset of the information
already captured in the PDB, i.e., about 43,000 entries
[35], and the Marseille Protein Crystallization Database
(MPCD) [36] combines an older version of the BMCD
with the CYCLOP database (no longer available) hav-
ing a total of about 15,000 entries. A few studies have
used these databases to suggest improved crystallization
strategies [37, 38], but their overall influence has been
limited. Over the last decade, however, a number of
crystallization facilities have also been gathering datasets
that contain the experimental details for each crystalliza-
tion attempt, for both positive and negative results. This
may open the road to types of analysis. Before detail-
ing these efforts, we first review advances made with the
datasets that existed prior to this advance.
IV. ANALYSIS OF SUCCESSFUL
CRYSTALLIZATION CONDITIONS
The most accessible and immediate source of informa-
tion about a macromolecule is whether a model of its
structure has been obtained from crystal or not up to
this point. Because of the intensity of the decades-long
efforts at obtaining such models, that information at least
reflects in part the experimental difficulty or facility of
crystallizing a target.
A. Prediction of crystallization propensity
Crystallization targets are typically chosen based on
two criteria: (i) their biological interest, and (ii) their
likeliness to crystallize. To evaluate the latter, a num-
ber of properties, such as the number of homologs that
have been successfully crystallized, chain length, the fre-
quency of charged residues, and the number of predicted
transmembrane helices have long been taken into account
[39]. More recently, a number of crystallization propen-
sity prediction tools have also been developed using struc-
tural information from the PDB and information about
the primary sequences that yield crystal structures or not
from databases such as TargetDB [40] and PepcDB (now
merged as TargetTrack) as well as UniRef50 [41]. These
tools infer from the primary sequence alone the proba-
bility with which a macromolecule can be crystallized,
which helps select targets more systematically.
SECRET [42] was one of the first such tools developed,
and was shortly followed by others, including OB-Score
[43], CRYSTALP [44], and ParCrys [45], but some of
these tools (SECRET and CRYSTALP) have since been
rendered obsolete by their low residue limit. In general,
the success of these predictors depends strongly on the
dataset with which they were trained. Newer training
sets are thought to yield better predictors in part because
advances in experimental techniques render crystallizable
some sequences that used to be deemed uncrystallizable.
Testing older prediction software with newer data thus
often reveals their lower predictive power. Some of these
tools also check features, such as the number of homologs
4of a given sequence in the PDB, which change with
time. In addition, OB-Score, CRYSTALP2 [46], Par-
Crys, SVMCRYS [47], MetaPPCP [48], and CRYSpred
[49] all use similar training datasets that, according to
Mizianty and Kurgan [39], are outdated as they were pre-
pared under the assumption that the sequences for which
the experiments have been stopped are uncrystallizable.
Quantitatively, the reported accuracy of these tools
can be measured by:
Accuracy =
TP + TN
TP + TN + FP + FN
(1)
where TP and TN are the number of true positives and
negatives, and FP and FN are the number of false pos-
itives and negatives. Note that this quantity gives, for
equal fractions of positive and negative results, a minimal
accuracy of 50%. The Matthews correlation coefficient
(MCC),
MCC =
TP× TN− FP× FN√
(TP + FP)× (TP + FN)× (TN + FP)× (TN + FN)
(2)
is also used, where a MCC=0 implies that the predic-
tion method does not do better than randomly picking
outcomes, while MCC=1 implies a complete predictive
power.
In what follows, we detail some of the tools available:
• XtalPred calculates and predicts several protein
properties from the primary sequence, including
the average hydrophobicity, pI, the frequency of
cysteines, methionines, tryptophans, tyrosines, and
phenylalanines, disordered regions, and transmem-
brane helices. The chain is then assigned a score
between one and five by comparing these properties
to the distribution of properties in TargetDB. A
score of five corresponds to very difficult to crystal-
lize and one means optimal for crystallization [50].
This prediction system was later expanded by using
random forest classifiers and by including surface
ruggedness, surface entropy and the surface amino
acid composition to the list of protein properties.
It was also renamed XtalPred-RF [51]. Note that
the use of random forest classifiers was first proto-
typed in RFCRYS [52]. This method was selected
because it was found to perform better compared to
support vector machine (SVM) and artificial neural
network methods. Both XtalPred and XtalPred-
RF have accuracies around 70%, but the latter has
a higher MCC of 0.47.
• PPCpred [39] and PredPPCrys [53] use a SVM
classifier of exposed and buried amino acid com-
positions, chain disorder, the proximity of certain
groups of amino acids and physicochemical prop-
erties of individual and collocated amino acids.
This large set of features (∼800 for PPCpred and
∼3000 for PredPPCrys) is then reduced to obtain
a best-performing set. In addition to predicting
crystallization probabilities given a sequence, both
PPCpred and PredPPCrys also predict the suc-
cess of other experimental steps, such as purifi-
cation and the production of well-diffracting crys-
tals. PredPPCrys uses an enhanced feature selec-
tion process, a two-level SVM classification system,
and an updated dataset. The PredPPCrys server
can predict a proteins propensity of yielding well-
diffracting crystals with 76% accuracy and an MCC
of 0.43, while PPCpred, when analyzed with the
same datasets, yields an accuracy of 64% and an
MCC of 0.25.
• SVMCRYS is an SVM-based method [47] that first
used a set of 116 protein features, including amino
acid frequencies (individually, in clusters and by
amino acid type) and physicochemical properties,
such as solvent accessible surface area, hydropho-
bicity and side chain hydrophobicity. A reduced
set of significant features was then identified. As
stated above, this method uses an earlier training
dataset, and hence its prediction accuracy drops
when tested with newer datasets [53]. The reported
accuracy was 87%, with MCC=0.74. It should also
be noted that when the same test set is used to as-
sess XtalPred, the accuracy (78%) and MCC (0.58)
were higher, while these values for ParCrys and
OB-Score did not differ significantly from what was
originally reported.
• PPCinter [54] is another SVM-based predictor that
predicts separately the outcome of the same exper-
imental steps as PPCpred. This method uniquely
takes into account inter-protein properties, such
as the amino acid composition in protein regions
predicted to be involved in protein-protein inter-
actions. The reported accuracy (80%) and MCC
(0.55) are about 3% and 0.03 higher, respectively,
than PPCpred.
• PXS assigns a crystallization probability to pro-
teins by incorporating features that were found to
be independent factors impacting crystallizability
informed by logistic regression studies, namely the
fraction of disordered residues, the average side
chain entropies of exposed residues, the fraction of
buried glycines, and the fraction of phenylalanine
[55]. By contrast to the other prediction servers
mentioned here, this system uses both the struc-
ture of crystallized proteins and their experimen-
tal propensity of crystallization success. However,
this tool, as well as MCSG Z-score [56], is limited
by its use data from only one structural genomics
center for training, and may thus perform poorly
in predicting crystallizability of proteins that dif-
fer substantially from those in this relatively small
training set. Logistic regression also cannot cap-
ture non-monotonic trends [57].
• XANNpred is an artificial neural network trained
5on a dataset from both PDB and sequence data
[58]. In total 428 protein properties were consid-
ered, including pI, average hydrophobicity and the
frequency of neighboring pairs of amino acids. The
accuracy for this method is between 75% and 81%
and MCC ranges from 0.50 to 0.63.
• SCMCRYS is an ensemble method that creates
scoring cards based on the identity of amino acid
pairs separated by 0 to 9 residues as set of features
[59]. The amino acid pairs are associated with a
score derived from the frequencies of the pair in
crystallizable and non-crystallizable proteins in the
training set. These scores are then optimized to
maximize the predictive power, and used to predict
the crystallizability of the given protein sequence.
This method uses the newer training datasets of
PPCpred. Its accuracy is found to be about 76%
and MCC about 0.44. Its authors note, however,
that the SVM-based PPCpred has a slightly bet-
ter performance, because it includes more features
and SVM can obtain more precise decision bound-
aries. One of the main purposes of this method
is to create more easily interpretable results than
those from machine learning.
In order to compare performances of the available pre-
dictors on an equal footing, it is crucial that the same
dataset (consisting of a wide variety of proteins) is used
to calculate accuracy, MCC, and other such measures.
Without such a comprehensive study, singling out a best
method for prediction is difficult. Nevertheless, based
on their relatively new training datasets, the wide range
of protein features considered, and the appropriateness
of the statistical methods chosen, tools such as PredP-
PCrys, PPCinter, and XtalPred-RF are expected to give
better guidance in selecting crystallization targets.
One should, however, keep in mind that most of these
methods use structural properties predicted from their
sequence alone, a process that is prone to error and
thus fundamentally limits the accuracy of the predictors
(and why crystallization is being attempted). This lim-
itation is reflected in the relatively low MCC they pro-
duce. Although they provide guidance, these tools are
far from being complete solutions to predicting outcomes
of crystallization trials. Marked improvements require a
better understanding of the microscopic properties that
promote crystallization and of the crystallization mech-
anisms themselves, in addition to the use of continually
updating training datasets.
B. Statistical analysis of databases and side chain
entropy reduction
The structural models in the PDB have also been
surveyed to identify macromolecular features that affect
crystallization and thus more specifically guide mutage-
nesis strategies. The most developed of these approaches
is the side chain entropy reduction (SER) method. The
method is motivated by the observation that immobi-
lizing side chains at crystal contacts between macro-
molecules has an entropic cost than can disfavor their
formation. This idea is also statistically supported by
an analysis of the correlation between protein structures
and crystallizability [57, 60]. SER thus advocates mu-
tating residues with high side chain entropies (SCE),
such as lysine, to lower SCE residues, such as alanine.
The approach was first successfully applied to Rho GDP-
dissociation inhibitor, chosen for its high lysine and glu-
tamate content and low crystallization propensity [61].
Although high SCE residues are predominantly found
at the surface of macromolecules, choosing among possi-
ble mutagenesis sites from the input amino acid sequence
alone is generally a non-trivial task. A more sophisti-
cated algorithm for SER was thus developed, and imple-
mented on the SERp server. It suggests residues for mu-
tation based on: (i) predictions of the secondary struc-
ture and the surface SCE, and (ii) sequence homology
to identify residues poorly conserved by evolution, and
thus likely less functionally or structurally relevant [62].
Residues are individually scored based on these two cri-
teria and, adjacent, high-scored residues are considered
potential sites for mutagenesis. Because removing too
many high SCE residues may reduce the solubility of the
macromolecule 1, the algorithm also minimizes the num-
ber of proposed mutations for a given SER target. In
the end SERp identifies mutations to lysine, glutamate,
and glutamine residues. Although successful mutagene-
sis cases have also mutated asparagine, SERp does not
allow it because that residue can also engage in favorable
protein-protein interactions. For a number of test cases,
the SER strategy has been shown to lead to the crystal-
lization of otherwise recalcitrant macromolecules, and to
improve the crystal quality of others [63]. Thus, protein
engineering, of which SER mutagenesis is an example, is
one of the means with which the experimental outcome
can be improved [61, 64, 65].
It should be noted that, although SER help attack the
crystallization problem, the physicochemistry of macro-
molecular crystallization is more intricate than the simple
label suggests. For instance, mutating lysine to arginine
is likely an alternative for the lysine to alanine mutation
despite them having nearly the same SCE because fa-
vorable electrostatic interactions that enthalpically drive
the formation of crystal contacts (with a nearby aspar-
tate, for instance) could otherwise be lost [28, 57, 63].
Experimental studies indeed show that the interaction
enthalpy of the aspartate-arginine pair is H=-6.3 kJ/mol,
but only H =1.3kJ/mol for the aspartate-lysine pair [66],
1 In addition to being potentially deleterious to protein solubility,
such mutations could also reduce the very structural stability of
the macromolecule. Nevertheless, it has been shown that stabil-
ity does not correlate with its crystallizability, unless the protein
is either unfolded (harder) or hyperstable (easier) [55]
6which is partly due to the aspartate-arginine pairs ability
to form two hydrogen bonds, compared to a single hydro-
gen bond between aspartate and lysine [67]. In addition,
hydrogen bonds, whose energy can range from ∼2 kJ/mol
to ∼20 kJ/mol [68], can more than compensate the high
SCE cost of binding with the backbone. These strong
enthalpic contributions thus make it less surprising that
some crystal contacts form despite their high SCE cost.
It should also be noted that while changing biochemical
conditions for crystallization is straightforward, altering
the macromolecule itselfas SER suggestsrequires that it
can be expressed, and therefore needs additional effort.
Although it may have a dramatic impact on outcome, it
is certainly not the easiest experimental route to follow.
V. ANALYSIS OF COMPLETE
CRYSTALLIZATION SCREENING DATA –
SUCCESS AND FAILURE
Although sparse and imperfect, crystallization screen-
ing, either through commercial kits or individual labora-
tory efforts, remains the most efficient method of probing
the phase diagram [30]. However, little to no information
(other than overall success or failure) has been extracted
from this screening process in general. In part, this is
within the very nature of the scientific enterprise as most
studies aim not to understand the fundamentals of crys-
tallization, but rather to obtain a structural model of the
macromolecule or complex studied. Compounded to this
cross-purpose, only the final crystallization condition is
usually reported - any initial screening results are masked
by the process of optimization where an iterative process
refines the initial promising screening result. Access to
a data or a database with complete and detailed experi-
mental information would allow a more complete study of
the effect of chemical conditions on crystallization proba-
bility and outcome in relation with macromolecular prop-
erties. Given the limited but important information that
has been gained from a binary crystal or no crystal analy-
sis of limited crystallization data, the results of such anal-
yses could be instructive about how to optimize screen
conditions and a lot more. We detail below two types of
insights that have been teased out of this analysis as well
as means to push this general idea forward.
A. New biological knowledge
We know that chemically related conditions are likely
to result in similar outcomes and, conversely, chemically
distinct conditions are likely to produce different out-
comes. This observation is fundamental to the design of
different crystallization screens for different classes of tar-
gets. This knowledge can be used to extract information
from crystallization screening of a single macromolecular
target if the chemical conditions can be mathematically
described and compared.
Newman et al. [69] pioneered a similarity metric,
termed the C6 metric, that assigns a quantitative value
to the similarity between two or more crystallization
cocktails, and allows those that are chemically similar
(through obvious, or less-apparent relationships) to be
distinguished from those that are chemically distinct. Us-
ing similar methods, related cocktails can be displayed
with hierarchical clustering and experimental outcomes
overlaid on the cluster [70]. Applying this approach to
an exopolyphosphatase-related protein from Bacteroides
fragilis, (BfR192) showed that biological information is
contained within the collection of crystallization screen-
ing outcomes. A fact that may not be apparent from
considering a single outcome alone successful or not. As
an example of this effect, BfR192, is a 343 residue protein
with a molecular weight of 39.77 kDa that was screened
in our laboratory using 1,536 different cocktails. Figure
2 overlays the location of specific cocktails that produced
crystals on the clustering of 1,536 different biochemical
conditions. Out of the 28 clusters, 11 produced at least
one crystal hit.
FIG. 2. Regions of crystallization space where hits for BfR192
were found. Out of the 28 clusters, 11 were identified contain-
ing at least one result determined visually to be crystalline.
Adapted from Bruno et al. [70].
Analyzing the outcomes, 70 conditions out of the full
1,536 produced initial crystallization hits. The highest
frequency of hits was in cluster 13 followed by cluster 14,
and then by cluster 12. In terms of the percentage of hits,
cluster 12 ranks as the first with 19% followed by cluster
13 with 18% yielding hits. (The total number of cocktails
in each cluster is variable due to the design of the screen
incorporating commercial screens which operate on dif-
fering principles, e.g. grid screening, identifying particu-
lar chemical species, the use of multiple small molecules,
7cryogenic compatibility or incomplete factorial sampling
of chemical space as used by the non-commercial condi-
tion sampling). Linking the clusters back to their chem-
istry, cluster 13 proved interesting in that sodium was
present in 73% of the conditions as opposed to 47% for
the 1536-condition-screen overall, potassium was present
in 72% of the conditions versus 24% overall and finally
phosphate was present in 100% of the conditions versus
16% overall.
The initial structure was deposited in the PDB with
undefined electron density. Based on the clustering anal-
ysis a sodium ion was placed in the structure, Figure 3,
which improved the electron density as did the inclusion
of a potassium ion and of four phosphates. The R and
Rfree reduced from 22.3% and 25.9% to 20.7% and 24.3%,
respectively. These ions also proved to be biologically
relevant. The location of the phosphate-binding pocket
suggests that the phosphoryl moieties of polyP might an-
chor in this pocket. The putative active site has features
that are consistent with active sites of other phosphatases
involved in binding the phosphoryl moieties of nucleotide
triphosphates [71]. A possible role of the active site phos-
phate is to ensure a proper substrate orientation and po-
larization of the phosphoryl P-O bond to increase the
susceptibility of the P atom to nucleophilic attack. The
space around the phosphate ions suggests that the cleft
can bind longer polyP substrates. An interesting obser-
vation was the lack of significant crystal formation in the
PEG-based conditions (cluster C20), demonstrating one
of the two classes of macromolecules revealed in the next
section.
FIG. 3. Structure of the BfR192 exopolyphosphatase-related
protein (PDB ID 4PY9) showing the two domains and high-
lighting the cleft containing the sodium, potassium and four
phosphate ions [70].
In short, the analysis of crystallization results from
the initial screen aided by a mathematical description of
chemical cocktail similarity identified the presence of ions
and a putative biological function. Even for a single tar-
get and only considering crystal or no-crystal outcomes,
the analysis of the crystallization results revealed new
biological information.
B. Analysis of crystallization propensity
From the description of the prediction schemes detailed
in Section 4, it is natural to wonder what cocktail prop-
erties lead to higher crystallizability. In order to produc-
tively conduct such a statistical analysis, it is crucial that
the dataset assayed systematically contains both positive
hits and negative results of crystallization experiments,
as well as details of the experimental conditions.
In this context, the Northeast Structural Genomics
consortium (NESG) database, which contains both the
crystallization outcome and the full description of chemi-
cal conditions for 1,536 cocktails, is an ideal model. From
an analysis of a subset of its content, one could statisti-
cally reconstruct the experimental crystallization propen-
sity, ξ, the fraction of hits based on structural features
of the macromolecules alone [57]. Such a reconstruction
revealed two mechanisms for crystallization: (i) driven
by SCE and, (ii) reliant on specific electrostatic interac-
tions. This nuance was also suggested by Price et al., in
a study of a subset of the NESG database [55], although
the statistical signature was not as clear. Interestingly,
this further dataset enabled studying the response in ξ
upon varying chemical conditions, which revealed that
proteins identified to crystallize with the second mecha-
nism have a propensity to crystalize with changes in salt
concentration rather than molecular crowding caused by
PEG, for example.
VI. TECHNICAL CONSIDERATIONS FOR
COMPUTATIONAL CRYSTALLIZATION
In order to expand the scope and capability of the
above analysis, we discuss here four technical considera-
tions.
A. Systematicity and completeness of datasets
A key prerequisite of the dataset for the study dis-
cussed in Section 5.2 was that ξ was obtained from ex-
periments that span the same chemical space. Compar-
ing results for different screens would be less reliable,
and changing the number of screens would bias the res-
olution of ξ, especially when it is small. The details of
the chemical composition are also essential. While some
steps have been made to account for this in other studies
with similarity metrics employed [57, 69], more detailed
knowledge of the chemical processes has to be captured.
For instance, the counter-ion identity can be important
to consider as different species can have different salting-
out abilities. Proper bookkeeping of chemical conditions
8and individual and combined properties also allows effi-
cient parsing of the data. Because increasing the number
and diversity of proteins in the dataset should help reveal
subtler trends, this effort could have a significant payoff.
B. Crystallization technique
For the studies described in Section 5, the ini-
tial method of crystallization was microbatch-under-oil.
With the exception of concentration changes due to de-
hydration through the plate, the microbatch method is
a static one, there is no dynamic change of component
concentration as occurs in vapor diffusion, the predom-
inant crystallization method. Although no systematic
study of the matter has been conducted, one may re-
fer to the physical basis of crystallization for insights.
Under-oil experiments keep the solution volume constant,
while vapor diffusion gradually supersaturates the pro-
tein solution as the droplet volume shrinks. Yet the
typical increase in concentration of salt and other co-
solutes change the pH and the chemical potential of the
co-solutes relatively little, because both depend logarith-
mically on solute concentration. The protein concentra-
tion, however, may change sufficiently for the system to
cross the phase boundary into the crystallization regime
and to significantly lower the barrier to nucleation (Fig-
ure 1). Hence, although the volume change and the con-
sequent change in the chemical properties of the solution
can likely be ignored in the analysis as a first approxima-
tion, the change in macromolecular concentration likely
cannot.
C. Optimization of Crystallization Conditions
Based on Screening
Commercial kits developed over many years of experi-
ence have made the initial crystallization screening pro-
cess relatively easy for most laboratories [7]. The devel-
opment of such screens involves taking an initial promis-
ing condition and changing the chemistry to optimize
that condition. This, however, has two shortcomings:
(i) optimization occurs around common fixed starting
points, and (ii) focus may be on the single best initial
result, causing separate but distinct clusters, as revealed
in the example from Section 5.2, to be overlooked. Con-
dition optimization is thus an important aspect that re-
quires attention in analyzing crystallization outcome as
it can impart an unintentional yet non-fictitious bias to
the results.
D. Characterizing outcome
To best utilize the theoretical knowledge of crystalliza-
tion, the experimental outcome has to be classified into
distinct regions of the protein phase diagram. The phase
diagrams obtained for model proteins (Section II) re-
lied on very defined crystallization screens with few vari-
ables. In reality, screening a structurally uncharacter-
ized macromolecule probes multiple variables. Given the
number of experiments required to cover that chemical
space, considerable effort is required to identify potential
crystal conditions, let alone other outcomes. When these
outcomes are noted for a single macromolecule, they can
be used to construct a vector for crystallization within
the surveyed chemical space [72]. However, human clas-
sification becomes an impediment when a multitude of
macromolecules are studied.
In a detailed study led by one of us, around 150,000 im-
ages of the crystallization plates from 96 distinct macro-
molecules were visually classified by a team of eight view-
ers such that each image was surveyed by a minimum of
three viewers. A control set unknown to the classifiers
was included at the beginning, middle and end of the
classification effort. Each image was visually classified
into seven categories: clear, phase separation, precipi-
tate, skin, crystals, junk, and unsure. Multiple classifi-
cations were allowed for all but clear. This not only cre-
ated a training set for automated image classification at-
tempts, but also revealed the reliability of humans in the
process. Using a deliberately strict definition of common
classifications (classifications had to be exactly equal),
the average agreement for classifications of the control
set was 78%. When comparing the whole data set, ap-
proximately 48% of the images were unanimously classi-
fied by three separate viewers. Again a deliberately strict
interpretation of agreement was used where multiple clas-
sifications, e.g. skin and precipitate, were regarded dif-
ferent from either skin, precipitate or the combination
and a third component. This work establishes a base-
line for automated classification success [4]. Using this
training set and extensive feature extraction approach,
automated classification can successfully recognize 80%
of crystal containing images, 94% of clear images and
94% of precipitate. Although this approach is promising,
the runtime is on the order of seconds per image using
high-end graphical processing units [73], which limits its
large-scale deployment.
Many other attempts have been made in automating
crystallization screening classification. To date none are
routinely available. A limiting factor in making use of the
complete information produced by crystallization screen-
ing is the efficient characterization of outcome.
VII. OUTLOOK FOR THE FUTURE
A fairly simple analysis of crystallization screening
outcome from multiple experiments on a single macro-
molecule shows that useful biological information can be
obtained. Not discussed here, but also a clear potential,
is the ability to distinguish between different states of a
macromolecule that may be present as a function of com-
mon crystallization conditions. A more global analysis
9on multiple macromolecules reveals two broad categories
that correspond to salt-based crystallization approaches
or other classes of precipitants. Membrane-bound macro-
molecules can be predicted and distinct crystallization
approaches used in those cases. These observations, cou-
pled with the success of commercial screens targeting spe-
cific macromolecular groups, e.g. nucleic acids, suggest
that crystallographic screening results contain both real
and useful information.
The theory of macromolecular crystallization is in-
creasingly well developed. Phase diagrams are fairly well
understood but the chemical space that needs to be sam-
pled for a biological macromolecule remains humongous.
With a more comprehensive description of chemical com-
ponents and their interactions, experimental outcome
classified on the basis of phase diagram regions, and accu-
rate information on the macromolecular sample including
those that fail, successful predictive techniques for both
screening and optimization should be within reach. Ad-
mittedly, these requirements are not trivial. Although
they are not necessary for producing an individual struc-
tural model, they are essential to advance the field of
crystallization, so that many more structural models can
be provided.
With only one in ten soluble macromolecules on aver-
age yielding a structural model today, advances in crys-
tallization success will likely have to be more dramatic
than deriving appropriate chemistry for optimizing con-
ditions. Mutation of the sample to improve the crystal-
lization properties appears to be the next step follow-
ing biochemical or biophysical (e.g. temperature) ap-
proaches. A full computational analysis of initial crystal-
lization screening would be more robust in determining
the most recalcitrant samples and prioritizing the molec-
ular biology approach.
Computational crystallization approaches are useful in
many cases. Achieving their full potential requires sig-
nificant increase in the amount and quality of available
data. To make this happen our high-throughput labo-
ratory and partners in similar laboratories around the
globe, which have privileged access and responsibility to
collect and curate these datasets, aim to keep on pioneer-
ing the analysis and the best practices. Yet, this work
can be a challenge to motivate in a conservative funding
context. The potential for computational crystallization
is thus here but remains to be fully realized.
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